Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript

Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc.

Related Keywords

Maryland ,United States ,Tennessee ,Japan ,America ,Jacquie Ross ,Salveen Richter ,Daina Graybosch ,Chris Schott ,Merdad Parsey ,Johanna Mercier ,Tyler Van Buren ,Andrew Dickinson ,Geoff Meacham ,Goldman Sachs ,Cindy Perettie ,James Shin ,Mohit Bansal ,Cindy Poretti ,Michael Yee ,James Shin At Deutsche Bank ,Gilead Sciences Inc ,Geoff Meacham At Bank ,Nasdaq ,Department Of Corrections ,Gilead Sciences ,Call Transcript April ,First Quarter ,Investor Relations ,Corporate Strategic ,Chief Executive Officer ,Danielo Day ,Chief Commercial Officer ,Chief Medical Officer ,Chief Financial Officer ,Executive Vice President ,Cymabay Acquisition ,Change Healthcare ,Tennessee Oncology ,Popular Retail Investor Stocks ,Radar Stocks With Massive Upside ,Umer Raffat ,Van Buren ,Thanks Tyler ,Maybei Ll ,